Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BetterLife Pharma Inc BETRF


Primary Symbol: C.BETR

Healthcare
BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be... see more

CSE:BETR - Post Discussion

BetterLife Pharma Inc > News out
View:
Post by mrBlockchain on Dec 08, 2020 9:13am

News out

Mind Medicine (MMED) valuation is $860m... BetterLife only $40m
Comment by elgin1 on Dec 08, 2020 9:29am
Seems like they have an interesting product . Management has proven track record in taking drugs to clinical market,  I hear Transcend guy is the guy who helped  synthesized Mindmends drug ? Anybody confirm that rumour ?
Comment by mrBlockchain on Dec 08, 2020 9:33am
I heard Mind Med were interested in their BOL-148 patent
Comment by elgin1 on Dec 08, 2020 9:36am
Mindmend seems like more of a pump and dump .Betr seems like it has an experienced team behind it .Let's see how it goes.
Comment by mrBlockchain on Dec 08, 2020 9:55am
BetterLife now has a good pipeline of drugs
BetterLife Pharma Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities